This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA experts advised two parties during both the CMA’s investigation and CAT Appeals, assessing the economic evidence and providing expert testimony on what prices could be considered excessive (or, to the contrary, consistent with competitive outcomes) in the UK market for Liothyronine tablets.
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...
CRA is pleased to announce that the following consultants have been recognized in Who’s Who Legal: Thought Leaders USA 2025.
Using a range of perspectives, including private practitioners in the United States and Canada, an antitrust economist and a representative from the...
CRA is a proud sponsor of the conference. Laurent Flochel is moderating the opening discussion. For more information on this event, click here.
